Her decades of work on Huntington’s disease helped lead to the creation of a genetic test for the devastating condition. Why didn’t she take it herself?
Emerging tests promise to screen for many cancers at once, but one just failed in a big trial. Will these diagnostics deliver on their promise someday?
Slow-healing lesions — common in diabetics and burn victims — can lead to lingering infections that resist antibiotic treatment. A new approach using light-activated therapies may offer a solution.
Researchers have uncovered a previously underappreciated mechanism involved in Alzheimer’s disease and developed a compound that interrupts it. For decades, Alzheimer’s research has largely focused on amyloid plaques and tau tangles, the protein abnormalities that accumulate in the brain as the disease progresses. Yet despite billions of dollars in research and numerous drug development efforts, [...]
Live Science spoke with Dr. Ali S. Khan, an epidemiologist and former assistant surgeon general of the U.S. Public Health Service, about the ongoing Ebola epidemic and the U.S.'s preparedness for future outbreaks.
A new study suggests that subtle changes in the brain’s immune cells could help explain why some people remain mentally sharp despite Alzheimer’s pathology. For decades, Alzheimer’s research has focused on the buildup of amyloid plaques and tau tangles, the two hallmark features of the disease. Yet a puzzling reality has continued to challenge scientists: [...]
A very early study suggests flu antivirals might help reverse certain signs of accelerated aging in people with HIV. But more research is needed to confirm these effects.
Scientists have uncovered an early brain mechanism that may help explain why people carrying the APOE4 gene face a higher risk of Alzheimer’s disease. For millions of people who carry the APOE4 gene, the strongest known genetic risk factor for Alzheimer’s disease, changes in brain activity may start years before memory problems become noticeable. Researchers [...]
Brown rot is a common fungal disease in the Southeastern United States that affects stone fruits like peaches, cherries, and plums. Monilinia fructicola is a tan, fuzzy fungus that grows on tree flowers, twigs, and fruit, and is the most common cause of brown rot. Once brown rot infects a tree, the damage is irreversible, causing significant crop losses in commercial orchards. Farmers try to control the spread of M. fructicola by applying chemical sprays, called fungicides, to fruit trees in the spring.
In M. fructicola, a biosynthesis gene named MfCYP51 encodes a major protein critical to the fungi’s survival. Certain fungicides, called demethylation inhibitor (DMI) fungicides, stop M. fructicola from growing by targeting this protein. Over the last 20 years, DMI fungicides have become less effective against brown rot as M. fructicola becomes more resistant.
Living microorganisms and their metabolites can control fungal diseases as an alternative to chemical fungicides, known as biofungicides. Many bacteria produce compounds like hydrogen cyanide and pyrrolnitrin that damage fungal cells. However, scientists have not found a biofungicide suitable for commercial production. A group of researchers at Clemson University in the USA and Huazhong Agricultural University in China set out to test whether the soil bacteria Pseudomonas chlororaphis and Bacillus subtilis could be effective biofungicides against brown rot.
The researchers performed an incubation experiment to analyze how the fungal cells make their critical protein from the MfCYP51gene, a process called gene expression, under different fungicide treatments. They used 3 M. fructicola strains sensitive to traditional DMI fungicides and 3 resistant strains. They tested these with 5 different fungicide treatments: a DMI fungicide, a mixture of P. chlororaphis metabolites, a mixture of living B. subtilis cells, a DMI fungicide + P. chlororaphis metabolites, and a DMI fungicide + B. subtilis cells. They also set up a control treatment with sterile water instead of fungicide.
After 6 hours, the researchers extracted the molecule that measures gene expression, called RNA, from the fungi. They found that both the P. chlororaphis treatment and the DMI fungicide + P. chlororaphis treatment substantially reduced MfCYP51 expression in both the sensitive and resistant isolates compared to the controls. In contrast, the DMI fungicide, B. subtilis, and DMI fungicide + B. subtilis treatments increased MfCYP51 expression in the resistant isolates. The researchers concluded that P. chlororaphis has a unique ability to reduce gene expression, unlike other biofungicides.
To further investigate how the biofungicide treatments work, the team tested whether P. chlororaphis and B. subtilis produced the anti-fungal metabolite pyrrolnitrin. They added 1 milliliter of each treatment to a machine that separates and identifies liquid compounds using high pressure, called a high-performance liquid chromatograph. They found that the P. chlororaphis treatment contained pyrrolnitrin, so they hypothesized that it was responsible for reducing gene expression.
Additionally, the researchers tested their 5 treatments on brown rot in fruit. For each treatment, they took 10 Gala apples, washed and sterilized their surfaces, and sprayed them with the fungicides. After 24 hours, they poked holes in the apples with toothpicks and added 20 microliters of liquid containing M. fructicola cells to the poked holes. They placed the apples in a humid chamber for 5 days and measured the number and size of brown rot spots that developed on their surfaces.
Despite decreasing MfCYP51 expression, the researchers found that P. chlororaphis treatment alone didn’t reduce brown rot disease compared to the control, but the DMI fungicide and B. subtilis treatments did. The mixed treatments of DMI fungicide + P. chlororaphis and DMI fungicide + B. subtilis both reduced brown rot disease compared to the control, but only the DMI fungicide + P. chlororaphis treatment prevented it.
The researchers concluded that although biofungicides may not be fully effective on their own, commercializing them could allow farmers to use less DMI fungicide. They explained that scaling back the use of DMI fungicides would slow M. fructicola resistance. Finally, they proposed that future researchers test biofungicide mixtures containing pyrrolnitrin in the field to observe real-world effects on stone fruit trees.
A new study shows that tau helps organize and preserve long-term memories, while abnormal tau may contribute to memory problems in Alzheimer’s disease by disrupting memory formation and recall. New research has revealed that tau, a protein closely linked to Alzheimer’s disease, is also essential for creating long-lasting memories. The findings could point to new [...]
Google has applied for an experimental mosquito release permit to deploy millions of non-biting southern house mosquitoes that it has infected with the bacterium Wolbachia pipientis, in an effort to reduce mosquito-borne diseases like West Nile virus.
The Curse resulted in decay, disease, and death affecting the entire creation, meaning the whole universe. The effects are seen in the cosmos and in living organisms. However a future restoration of creation is promised by God, reversing the effects of the Curse.
Excess deaths linked to Covid vaccines in Australia, alarming death and disease surges identified in Japan, and humanitarian crises in Gaza are in the news. But there is hope. Death is the last enemy which will be conquered by Jesus Christ.
Two new tool compounds may help scientists study TAOK proteins linked to Alzheimer’s disease and other neurological disorders. Alzheimer’s disease is the leading cause of dementia and affects more than seven million people in the United States. Some treatments can slow the disease, but most address symptoms rather than the root biology, and none can [...]
Researchers are testing CAR T cell therapy as a way to reset the immune system in lupus, Graves’ disease and other conditions where the body’s defenses go rogue
Login
Researchers have uncovered a previously underappreciated mechanism involved in Alzheimer’s disease and developed a compound that interrupts it. For decades, Alzheimer’s research has largely focused on amyloid plaques and tau tangles, the protein abnormalities that accumulate in the brain as the disease progresses. Yet despite billions of dollars in research and numerous drug development efforts, [...] 
A rare inflammatory condition linked to tattoos is appearing more often in Australia. 
A contraceptive drug helps human nerve cells regenerate by unlocking their forgotten embryonic healing abilities. 
A new study suggests that subtle changes in the brain’s immune cells could help explain why some people remain mentally sharp despite Alzheimer’s pathology. For decades, Alzheimer’s research has focused on the buildup of amyloid plaques and tau tangles, the two hallmark features of the disease. Yet a puzzling reality has continued to challenge scientists: [...] 
Scientists have uncovered an early brain mechanism that may help explain why people carrying the APOE4 gene face a higher risk of Alzheimer’s disease. For millions of people who carry the APOE4 gene, the strongest known genetic risk factor for Alzheimer’s disease, changes in brain activity may start years before memory problems become noticeable. Researchers [...] 
A new study shows that tau helps organize and preserve long-term memories, while abnormal tau may contribute to memory problems in Alzheimer’s disease by disrupting memory formation and recall. New research has revealed that tau, a protein closely linked to Alzheimer’s disease, is also essential for creating long-lasting memories. The findings could point to new [...] 
Two new tool compounds may help scientists study TAOK proteins linked to Alzheimer’s disease and other neurological disorders. Alzheimer’s disease is the leading cause of dementia and affects more than seven million people in the United States. Some treatments can slow the disease, but most address symptoms rather than the root biology, and none can [...] 
